Loading stock data…
$17.62-0.78 (-4.24%)
MiniMed Group, Inc.
| Metric (USD) | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Total Revenue | $843.00M↑ | $837.00M↑ | $790.00M↑ | $752.00M↑ | $723.00M |
| Gross Profit | $465.00M↓ | $480.00M↑ | $362.00M↓ | $428.00M↑ | $409.00M |
| Operating Income | $2.00M↑ | -$87.00M↑ | -$93.00M↓ | -$10.00M↓ | $3.00M |
| Net Income | $0↑ | -$185.00M↓ | -$119.00M↓ | -$27.00M↓ | -$19.00M |
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens...